FOXO4-DRI is a peptide antagonist designed to block the interaction of forkhead box O 4 (FOXO4) and p53.
FOXO4-DRI, also known as FOXO4-p53 interfering peptide, represents a breakthrough peptide compound designed to modulate cellular pathways associated with senescence and apoptotic regulation. Developed through advanced peptide engineering, FOXO4-DRI mimics a critical domain of the FOXO4 transcription factor, enabling it to disrupt specific protein-protein interactions within the cell nucleus. This targeted approach allows researchers to selectively influence the fate of senescent cells, a process that is gaining increasing attention in the fields of aging, regenerative biology, and disease modeling. The unique structure and mechanism of action of FOXO4-DRI make it an invaluable tool for laboratories seeking to dissect the molecular underpinnings of cellular aging and to explore novel strategies for tissue rejuvenation and functional restoration.
Senescence Research: As a potent modulator of the FOXO4-p53 axis, FOXO4-DRI is widely utilized in studies investigating the mechanisms of cellular senescence. By selectively disrupting the interaction between FOXO4 and p53, the peptide enables researchers to induce apoptosis in senescent cells while sparing healthy, proliferating counterparts. This selective clearance is instrumental for dissecting the role of senescent cells in tissue dysfunction and aging, providing a robust platform to explore the consequences of senescence removal in vitro and in animal models. The peptide's ability to target senescent cell populations has facilitated the identification of key biomarkers, improved understanding of senescence-associated secretory phenotypes, and contributed to the development of innovative anti-aging strategies.
Aging and Longevity Studies: FOXO4-DRI has emerged as a critical tool in the exploration of aging processes and longevity interventions. Researchers employ this compound to assess the impact of senescent cell clearance on tissue homeostasis, organ function, and lifespan extension in various biological systems. By enabling precise modulation of the senescent cell burden, the peptide allows for controlled experiments that elucidate the interplay between cellular aging and systemic health. Its application has led to significant insights into how the accumulation of senescent cells contributes to age-related decline and how their removal may restore youthful tissue characteristics, thus advancing the field of geroscience.
Regenerative Medicine: In regenerative biology, FOXO4-DRI is leveraged to enhance tissue repair and regeneration by mitigating the inhibitory effects of senescent cells. Accumulation of senescent cells is known to impair tissue regeneration and promote chronic inflammation, posing significant challenges in wound healing and organ recovery. By facilitating the selective elimination of these dysfunctional cells, the peptide supports a more favorable microenvironment for stem cell activity and tissue renewal. This application is particularly valuable in experimental models aiming to optimize strategies for regenerative therapies and to improve the integration and function of transplanted cells or engineered tissues.
Cancer Biology: The role of FOXO4-DRI in cancer research is gaining prominence due to its capacity to manipulate the senescence-associated tumor microenvironment. Senescent cells within tumors can contribute to therapy resistance, inflammation, and tumor progression. By targeting these cells, the peptide offers a novel approach to modify the tumor milieu, potentially enhancing the efficacy of anticancer treatments and reducing adverse effects associated with conventional therapies. Researchers utilize FOXO4-DRI to investigate the dynamic interactions between senescent cells and cancer cells, aiming to uncover new therapeutic targets and to develop combinatorial treatment strategies.
Drug Discovery and Screening: FOXO4-DRI serves as a valuable tool in high-throughput screening platforms for the identification of new compounds that modulate senescence and related pathways. Its well-characterized mechanism of action provides a reliable benchmark for evaluating the potency and selectivity of candidate molecules. By incorporating this peptide into drug discovery pipelines, scientists can accelerate the development of next-generation senolytics and related therapeutics. Additionally, the peptide's application in screening assays helps to unravel the downstream effects of senescent cell clearance, facilitating the translation of basic research findings into innovative solutions for age-associated diseases and tissue degeneration.
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More